The North America blood collection tubes market is highly consolidated in nature, with Becton, Dickinson, and Company being the torch bearer in the arena. According to a study by Transparency Market Research (TMR), the market in the region is highly lucrative for players with strong product/technical expertise. The soaring demand for new, improved, and safe blood collection technologies are encouraging market players to pay high attention towards product innovation and technological advancements.
“Companies operating in the serum samples segment are likely to register greater profit and rake in a sustainable share of the overall market revenue,” says TMR’s lead analyst. Some other prominent companies operating in the North America market for blood collection tubes are Medtronic, Qiagen N.V, Terumo Corporation, and Greiner Bio-One. The market is poised to rise to a valuation of US$632.1 mn by 2023, progressing at an 8.6% CAGR from 2015 to 2023.
Request A Sample-
Favorable Government Initiatives to Back Dominance of U.S.
On the basis of product, the serum separating tubes segment will continue to be at the forefront of the North America blood collection tubes market until 2023. Rapid serum tubes will expand at a CAGR higher than any other segment during the review period, owing to the introduction of advanced technologies. Geographically, the U.S. will account for the lion’s share in the market throughout the forecast horizon. The growth of the region can be attributed to the widening base of geriatrics and introduction of conducive government initiatives.